Revive Therapeutics (TSXV:RVV; OTCQB:RVVTF) offered shareholders an update on the development of an Artificial Intelligence (AI) element for their proprietary patient-focused program dedicated to the medical cannabis industry enabled by Blockchain technology.
As quoted in the press release:
This update follows Datametrex AI Limited (“Datametrex”) (TSX VENTURE:DM)(FRANKFURT:D4G) recent announcement of Datametrex’s wholly owned subsidiary, Nexalogy Environics Inc. (“Nexalogy”), entered into a license and development agreement with Revive.
Revive is aiming to incorporate Nexalogy’s proprietary social data discovery solution, NexaIntelligence, to unlock the value of data related to medical cannabis collected from social media networks and internet environments such as discussion forums, blogs and news sites. Through data mining and analytics, information aggregated from independent sources on the internet will aim to provide authentic insights and uses of cannabis on a variety of medical conditions. With its unique, easy-to-understand visuals in a highly functional interface, NexaIntelligence, is able to conduct a deep analysis of the ever-growing volume of online data of medical cannabis and catch the valuable signals that lead to strategic insights and actionable intelligence.